TY - JOUR
T1 - Treatment of venereal disease in the penicillin-allergic patient
T2 - administration of penicillin following testing with major and minor determinants.
AU - Greenberger, P. A.
AU - Phair, J. P.
PY - 1985
Y1 - 1985
N2 - We describe the administration of penicillin for venereal disease in three penicillin-allergic patients for whom alternative antibiotics were not considered suitable. Each patient was skin test negative to the major penicillin determinant benzylpenicilloyl-polylysine and a minor determinant mixture of potassium penicillin, benzylpenicilloate and benzylpenicilloyl-n-propylamine provided by the National Institute of Allergy and Infectious Diseases. Therapeutic doses of penicillin were administered without anaphylaxis, but one patient developed serum sickness on day five following benzylpenicillin. The skin testing results were determined within 30 minutes such that penicillin or its derivatives could be administered safely and rapidly to seriously ill patients, i.e. disseminated gonococcemia. When treating neurosyphilis or disseminated gonococcal infection for which non-penicillin therapy is unacceptable, use of the current skin test reagents provides a level of safety in avoiding anaphylaxis not previously attainable.
AB - We describe the administration of penicillin for venereal disease in three penicillin-allergic patients for whom alternative antibiotics were not considered suitable. Each patient was skin test negative to the major penicillin determinant benzylpenicilloyl-polylysine and a minor determinant mixture of potassium penicillin, benzylpenicilloate and benzylpenicilloyl-n-propylamine provided by the National Institute of Allergy and Infectious Diseases. Therapeutic doses of penicillin were administered without anaphylaxis, but one patient developed serum sickness on day five following benzylpenicillin. The skin testing results were determined within 30 minutes such that penicillin or its derivatives could be administered safely and rapidly to seriously ill patients, i.e. disseminated gonococcemia. When treating neurosyphilis or disseminated gonococcal infection for which non-penicillin therapy is unacceptable, use of the current skin test reagents provides a level of safety in avoiding anaphylaxis not previously attainable.
UR - http://www.scopus.com/inward/record.url?scp=0022022059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022022059&partnerID=8YFLogxK
U2 - 10.2500/108854185779045242
DO - 10.2500/108854185779045242
M3 - Article
C2 - 3870499
AN - SCOPUS:0022022059
SN - 0742-2814
VL - 6
SP - 166
EP - 169
JO - New England and regional allergy proceedings
JF - New England and regional allergy proceedings
IS - 2
ER -